These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25154199)

  • 1. [The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization].
    Zuziak S; Topór-Madry R; Pilc A; Bochenek T
    Pol Merkur Lekarski; 2014 Jul; 37(217):43-8. PubMed ID: 25154199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Costs of a cytostatic drug preparation unit in a hospital in Mexico].
    Martínez Rodríguez OA; Rivas Bocanegra RE; Ascencio-Pérez IS; Zapata Sánchez LA
    Farm Hosp; 2007; 31(6):375-8. PubMed ID: 18348668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reusing cytostatics in a centralised pharmacy preparation unit.
    Ramos Linares S; Merino Alonso J; Román González N; Tévar Alfonso E; Díaz Ruíz P; Gorchs Molist M
    Farm Hosp; 2011; 35(2):70-4. PubMed ID: 20869287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ; Maher M
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacy-managed drug supply may reduce drug expenditure in hospitals].
    Trapnes E; Gløersen E; Mordal K; Refsum N
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1205-6. PubMed ID: 15880162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economical assessment of intravenous mixture centralization].
    Martínez-Tutor MJ
    Farm Hosp; 2006; 30(6):351-8. PubMed ID: 17298192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic assessment of aseptic compounding rooms in hospital pharmacies in five European countries.
    Dekyndt B; Décaudin B; Lannoy D; Odou P
    J Oncol Pharm Pract; 2015 Apr; 21(2):102-10. PubMed ID: 24519187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of drugs manufactured by the university hospital--role of the Central Pharmacy.
    Marin ML; Chaves CE; Zanini AC; Faintuch J; Faintuch D; Cipriano SL
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(2):41-6. PubMed ID: 11460203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASHP national survey of hospital-based pharmaceutical services--1992.
    Crawford SY; Myers CE
    Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centralized intravenous additive services (CIVAS): the state of the art in 2010.
    Hecq JD
    Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic consumption and its costs of purchase in Polish neonatology networks units].
    Rózańska A; Wójkowska-Mach J; Borszewska-Kornacka M; Cmiel A; Gadzinowski J; Gulczyńska E; Helwich E; Kordek A; Pawlik D; Szczapa J; Heczko PB
    Przegl Epidemiol; 2012; 66(3):513-9. PubMed ID: 23230725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy management strategies for responding to hospital reimbursement changes.
    Curtiss FR
    Am J Hosp Pharm; 1983 Sep; 40(9):1489-92. PubMed ID: 6353913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients.
    Cuesta-López I; Sánchez-Cuervo M; Candela-Toha Á; Benedí-González J; Bermejo-Vicedo T
    Farm Hosp; 2018 Mar; 42(2):62-67. PubMed ID: 29501057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost of functioning of a centralised pharmaceutical unit: evaluation of mean costs of chemotherapy preparations according to the level of production of the unit].
    Galy G; Bauler S; Buchi M; Pirot F; Pivot C
    Bull Cancer; 2011 Oct; 98(10):1153-63. PubMed ID: 22001702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis for reimbursement-rate setting of hospital pharmaceutical services in Thailand.
    Riewpaiboon A; Kumluang S;
    Int J Pharm Pract; 2011 Oct; 19(5):333-41. PubMed ID: 21899613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big savings. Aggressive pharmacy management yields big savings.
    Hosp Health Netw; 2013 Dec; 87(12):21. PubMed ID: 24494421
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacy computer system at The Ohio State University hospitals.
    Moore TD; Dzierba SH; Miller A
    Am J Hosp Pharm; 1984 Nov; 41(11):2384-9. PubMed ID: 6507442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.